impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
Published 5 years ago • 1.2K plays • Length 7:08Download video MP4
Download video MP3
Similar videos
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
2:30
impassion130: immunotherapy for tnbc
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...
-
4:27
the impassion130 study in metastatic tnbc
-
2:52
impassion130 study: improvement in os and pfs for iit and pd-l1 populations with mtnbc
-
0:47
atezolizumab for tnbc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
3:50
breast cancer at esmo 2020: impassion131, solar-1, pallas and more
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
4:33
i-o in tnbc: impassion130 trial design and results
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
4:53
results from the impassion130 trial for triple-negative breast cancer
-
1:16
dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
6:54
impassion130 trial data on pd-l1 tumors in tnbc
-
3:35
final results of pakt: capivasertib and paclitaxel for tnbc
-
4:46
performance of pd-l1 ihc assays in impassion130: a post-hoc analysis